Meta AnalysisID 3887

灵芝多糖提取物及其抗肿瘤活性:体外/体内模型的系统评价

CRD42021296200

Do Ganoderma lucidum polysaccharide extracts show inhibitory activity against cancer in in vitro/in vivo models? Context and rationale This study will compile information about the therapeutic effect of Ganoderma lucidum

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
3887
Evidence Id
12445
Core Evidence Id
12445
Source Meta Analysis Id
3844
Herb2 Meta Analysis Id
HBMA003844
Crd Id
CRD42021296200
Title
Ganoderma lucidum polysaccharide extracts and their antineoplastic activities – A Systematic Review of in vitro/in vivo models
Review Question
Do Ganoderma lucidum polysaccharide extracts show inhibitory activity against cancer in in vitro/in vivo models? Context and rationale This study will compile information about the therapeutic effect of Ganoderma lucidum polysaccharides or polysaccharide extracts on cancer models (in vitro or in vivo). This data are extremely important to provide a safe direction for clinical trials that may be performed using Ganoderma lucidum polysaccharides for treating human cancers.
Study Type Included
Inclusion criteria: Controlled studies with a separate control group, non-clinical experimental studies. Exclusion criteria: Case studies, crossover studies, controlled trial, cohort studies.
Condition Being Studied
Participant
Animal
Inclusion criteria: All murine models (mice or rats) with experimental cancer with or without metastasis, all in vitro models using cancer cell lines (in vitro). Exclusion criteria: Animals with co-morbidities; animals other than mice or rats; in silico models; other cells lineages than cancer; ex vivo samples.
Human Disease Modelled
Cancer; Neoplasms.
Intervention
Inclusion criteria: Anticancer treatment with Ganoderma lucidum polysaccharides or polysaccharide extracts, including pretreatment of tumor cells. All treatment times, frequencies and dosages are eligible for inclusion. Exclusion criteria: Studies of other type of mushroom extracts, studies of polysaccharides linked to any other compounds (e.g., peptides, antibodies, nanoparticles) will not be selected.
Comparator Control
Inclusion criteria: Appropriate control: vehicle treated control animals. Vehicle treated control cells. Exclusion criteria: All other control conditions (e.g., no treatment, treated with saline if vehicle is not saline). Sham group, placebo group, or animals not treated with vehicle.
Main Outcome
Outcome Measure
Inclusion criteria: In vivo: tumor weight, tumor volume, biochemical and molecular assays on tumor tissue to determine the effects or mechanism of action of Ganoderma lucidum polysaccharides or polysaccharide extracts. In vitro: cell viability, proliferation, migration, biochemistry and molecular assays. Exclusion criteria: No relevant results reported (e.g., just reporting cell viability without further testing).
Additional Outcome
Study Method
Keyword
Animals; Antineoplastic Agents; Dietary Carbohydrates; Plant Extracts; Polysaccharides; Reishi
Contact
Fhernanda Smiderle [email protected]
Organisational Affiliation
Instituto de Pesquisa Pele Pequeno Principe - http://www.pelepequenoprincipe.org.br/ http://www.pelepequenoprincipe.org.br/
Funding Source
Associação Hospitalar de Proteção a Infância Dr. Raul Carneiro, sponsor of Instituto de Pesquisa Pelé Pequeno Príncipe
Other Selection Criteria
Inclusion criteria: Original articles in the period 2011-2022 in index journals. Exclusion criteria: Articles outside the 2010-2022 period, in journals without impact factor, review article, clinical trials, conferences, book chapter, book.
Final Publication
Same Topic Review
Not applicable
Published Protocol
Review Type
Pre-clinical animal intervention review
Language
English
Country
Brazil
Review Stage
Review Ongoing
First Submission Date
2021-12-03
Registration Date
2021-12-13
Anticipated Start Date
2021-09-02
Anticipated Completion Date
2022-08-02
Title Cn
灵芝多糖提取物及其抗肿瘤活性:体外/体内模型的系统评价
Title En
Ganoderma lucidum polysaccharide extracts and their antineoplastic activities – A Systematic Review of in vitro/in vivo models
Bilingual Status
complete